HUMA earnings: a negative outcome, -6.5%

On May 12, 2023, Humacyte, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.5% in the window around the event. It had already run +27.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.